Peripheral Administration of an Opioid Peptide Analog Ameliorates Morphine-Produced Hyperalgesia in a Spared Nerve Injury Model

Wang, Yuan; Ma, Miling; Wang, Jing; Han, Chao-Zhen-Yi; Li, Kai; Ru, Qiao-min; Li, Na; Liu, Xin; Wang, Rui

doi:10.1007/s10989-021-10319-4

Cited by 1 publication

(1 citation statement)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These divisions are characterized by hallmark symptoms of hyperalgesia and allodynia. Hyperalgesia entails a diminished pain threshold or an intensified pain response to otherwise milder pain stimuli, while allodynia signifies the emergence of pain in response to stimuli that are typically innocuous in nature (Forstenpointner et al, 2019; Wang et al, 2022). Furthermore, individuals experiencing neuropathic pain often exhibit heightened pain perception and endure spontaneous pain episodes (Meacham et al, 2017).…”

Section: Potential Use Of Resveratrol In Neuropathic Pain Managementmentioning

confidence: 99%

Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance

Wang,

Jiang,

et al. 2023

Phytotherapy Research

View full text Add to dashboard Cite

Pathological pain, a multifaceted and debilitating ailment originating from injury or post‐injury inflammation of the somatosensory system, poses a global health challenge. Despite its ubiquity, reliable therapeutic strategies remain elusive. To solve this problem, resveratrol, a naturally occurring nonflavonoid polyphenol, has emerged as a potential beacon of hope owing to its anti‐inflammatory, antioxidant, and immunomodulatory capabilities. These properties potentially position resveratrol as an efficacious candidate for the management of pathological pain. This concise review summaries current experimental and clinical findings to underscore the therapeutic potential of resveratrol in pathological pain, casting light on the complex underlying pathophysiology. Our exploration suggests that resveratrol may exert its analgesic effect by the modulating pivotal signaling pathways, including PI3K/Akt/mTOR, TNFR1/NF‐κB, MAPKs, and Nrf2. Moreover, resveratrol appears to attenuate spinal microglia activation, regulate primary receptors in dorsal root sensory neurons, inhibit pertinent voltage‐gated ion channels, and curb the expression of inflammatory mediators and oxidative stress responses. The objective of this review is to encapsulate the pharmacological activity of resveratrol, including its probable signaling pathways, pharmacokinetics, and toxicology pertinent to the treatment of pathological pain. Hopefully, we aim to map out promising trajectories for the development of resveratrol as a potential analgesic.

show abstract

Section: Potential Use Of Resveratrol In Neuropathic Pain Managementmentioning

confidence: 99%

Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance

Wang,

Jiang,

et al. 2023

Phytotherapy Research

View full text Add to dashboard Cite

show abstract

Peripheral Administration of an Opioid Peptide Analog Ameliorates Morphine-Produced Hyperalgesia in a Spared Nerve Injury Model

Cited by 1 publication

References 48 publications

Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance

Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance

Contact Info

Product

Resources

About